Company Filing History:
3 out of 12 
3 out of 5 Years Active: 2018-2024
Title: Steven Wayne Riesinger: Innovator in Cerebral Treatments
Introduction: Steven Wayne Riesinger, an accomplished inventor based in Boston, MA, has made significant contributions to the field of medical innovations. With a portfolio of five patents, he has focused primarily on developing treatments for cerebral conditions.
Latest Patents: Among his noteworthy inventions, one of his latest patents addresses the "Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors." This patent outlines methods for effectively treating cerebral cavernous malformations (CCM) and cerebral aneurysms in mammals using specific rho kinase inhibitors. Another significant patent involves "Methods for improved protection and delivery of aminothiols and analogs thereof," detailing an aminothiol-conjugate designed for therapy, as well as methods for administering this treatment to patients in need.
Career Highlights: Steven has been associated with prominent companies such as Bioaxone Biosciences and The Burlington Healthcare Research Group. His work at these organizations has allowed him to innovate and push the boundaries of medical treatment options.
Collaborations: Throughout his career, Steven has collaborated with distinguished peers, including Kenneth M. Rosen and Lisa McKerracher. These collaborations have fostered a rich environment for scientific discovery and advancement.
Conclusion: Steven Wayne Riesinger continues to make a mark in the field of medical inventions with his pioneering patents and collaborative efforts. His dedication to improving treatment options for cerebral conditions significantly impacts patient care and the broader medical community.